Filing Details

Accession Number:
0001637904-17-000001
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-02-15 16:50:46
Reporting Period:
2017-02-13
Filing Date:
2017-02-15
Accepted Time:
2017-02-15 16:50:46
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
926617 Vermillion Inc. VRML In Vitro & In Vivo Diagnostic Substances (2835) 330595156
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1637904 Fred Ferrara C/O Vermillion, Inc.
12117 Bee Caves Rd Bldg 3 Ste 100
Austin TX 78738
Chief Operating Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, Par Value $0.001 Acquisiton 2017-02-13 6,695 $1.40 6,695 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Warrants (Right to buy) Acquisiton 2017-02-13 5,021 $0.13 5,021 $1.80
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
5,021 2017-08-17 2022-02-17 No 4 P Direct